[Form 4] BioSig Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Streamex Corp. (STEX) reported that a director received a grant of 125,000 shares of common stock as a restricted stock award on November 18, 2025 under the company’s 2023 Equity Incentive Plan. The award was valued using a closing share price of $4.14 on the grant date and will vest in full on the one-year anniversary of that date. Following this grant, the director beneficially owns 228,345 shares of Streamex common stock, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Browne Donald

(Last) (First) (Middle)

C/O STREAMEX CORP.

2431 ALOMA AVE STE 243

(Street)

WINTER PARK FL 32792

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Streamex Corp. [ STEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		A		125,000	A	$0(1)	228,345	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock award was granted under the Company's 2023 Equity Incentive Plan as of November 18, 2025 (the "Date of Grant"), based on a closing price of $4.14 per share on such date; the shares vest in full on the one year anniversary of the Date of Grant.

	/s/ Karl Henry McPhie attorney-in-fact	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Streamex Corp. (STEX) report on this Form 4?

A Streamex Corp. director reported receiving a restricted stock award of 125,000 shares of common stock on November 18, 2025.

What is the grant date and vesting schedule of the Streamex (STEX) restricted stock award?

The restricted stock award was granted on November 18, 2025 and the 125,000 shares vest in full on the one-year anniversary of the grant date.

What price was used to value the Streamex (STEX) restricted stock grant?

The award was based on a closing price of $4.14 per share for Streamex common stock on November 18, 2025.

How many Streamex (STEX) shares does the director own after the reported transaction?

After the restricted stock grant, the director beneficially owns 228,345 shares of Streamex common stock in direct ownership.

Was the Streamex (STEX) Form 4 filed for one reporting person or a group?

The Form 4 indicates it was filed by one reporting person, not by more than one reporting person.

What equity plan was used for the Streamex (STEX) restricted stock award?

The 125,000-share restricted stock award was granted under Streamex Corp.’s 2023 Equity Incentive Plan.